(a) At least 30 days before the event in which the athlete intends to compete, (1) a transgender female athlete who applies to compete in women's competitions, or (2) a transgender male athlete who applies to compete in men's competitions, shall submit their Application.
(1) No Application will be granted on an emergency basis.
(2) No Application will be granted on a retroactive basis.
(b) Transgender female athletes who apply to compete in women's competitions:
(1) A transgender female athlete who has had a gonadectomy shall also include as part of her Application:
(A) Written confirmation by a State-licensed physician or Doctor of Osteopathic Medicine has confirmed that hormone therapy has been administered by a Health Care Provider for a minimum of 2 years after gonadectomy.
(B) A letter from the State-licensed physician or Doctor of Osteopathic Medicine responsible for the care of the applicant that must include the following:
(i) Name of surgeon who performed the gonadectomy and the date and location of surgery;
(ii) Initial date hormone therapy began after gonadectomy (and prior to surgery, if relevant);
(iii) Hormone name/type, dose and interval of administration over the past two years;
(iv) Name, dose and duration of any anti-androgen treatment used over the past two years.
(2) A transgender female athlete who is undergoing hormone therapy but has not had a gonadectomy shall also include as part of her Application:
(A) Written confirmation by a State-licensed physician or Doctor of Osteopathic Medicine that hormone therapy has been administered by a Health Care Provider for a minimum of two years.
(B) A letter from the State-licensed physician or Doctor of Osteopathic Medicine responsible for the care of the applicant that must include the following:
(i) Initial date hormone therapy began;
(ii) Hormone name/type, dose and interval of administration over the past two years;
(iii) Lab reports of estradiol and testosterone levels with a goal of serum estradiol levels within the normal range for healthy premenopausal women (lab specific) and suppression of testosterone levels to those normally found in women (lab specific) for the past two years;
(iv) Name, dose and duration of any anti-androgen treatment used over the past two years.
(c) Transgender male athletes who apply to compete in men's competitions:
(1) The athlete's Application shall also include:
(A) Confirmation from a State-licensed physician or Doctor of Osteopathic Medicine that hormone therapy has been administered by a Health Care Provider for a minimum of 2 years.
(B) A letter from the State-licensed physician or Doctor of Osteopathic Medicine responsible for the care of the applicant that must include the following:
(i) Initial date of hormone therapy;
(ii) Hormone name/type, dose and interval of administration for the past six months;
(iii) Lab reports of estradiol and testosterone levels for the past six months with a goal of serum estradiol levels within the normal range for healthy men (lab specific) and testosterone levels within the range for healthy men (lab specific).
(d) If the commission denies an Application submitted pursuant to this Chapter, the athlete may appeal that decision; such appeal must be submitted in writing to the commission within seven (7) days of the Commission's decision. The commission will set the matter for hearing within thirty (30) days.
Credits
Note: Authority cited: Section 18611, Business and Professions Code. Reference: Sections 18640, 18642, 18648, 18660, 18661, 18711 and 18712, Business and Professions Code.
